CHARLES MADDIX: Open Payments
NPI 1790047926 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,337 in 48 payments from 14 companies in 2025. Trend: 2023 $1,698 · 2024 $2,142 · 2025 $1,337
Food & beverage: $1,337
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $190 |
| ABBVIE INC. | 4 | $184 |
| E.R. Squibb & Sons, L.L.C. | 3 | $147 |
| Lundbeck LLC | 6 | $140 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $127 |
| Bausch Health US, LLC | 6 | $119 |
| Neos Therapeutics, LP | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $83 |
| Corium, LLC | 5 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $64 |
Products named: VRAYLAR, COBENFY, REXULTI, CAPLYTA, VIVITROL, APLENZIN, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across FL — which companies pay providers there.
